Learning Objectives:
1) Describe the key takeaways from the recommendations outlined in the “GOLD Report 2025 – Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease.”
2) Discuss the general characteristics of evidence-based, pharmacologic & non-pharmacologic treatments for patients diagnosed with COPD.
3) Develop an individualized, evidence-based treatment plan (including non-pharmacologic & pharmacologic interventions) for a patient diagnosed with COPD
Accreditation Statement for DOCME programs:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Mississippi Osteopathic Medical Association (MOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
Disclosure:
A. Joseph Nosser, PharmD has no actual or potential conflict of interest in relation to this program or presentation.
Grievance Statement:
All grievances may be directed to MOMA's Executive Director at info@moma-net.org. All grievances will receive an initial response within 30 days of receipt. If the participant does not receive a satisfactory response, they can submit a complaint to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.